AU6849500A - Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interest - Google Patents
Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interestInfo
- Publication number
- AU6849500A AU6849500A AU68495/00A AU6849500A AU6849500A AU 6849500 A AU6849500 A AU 6849500A AU 68495/00 A AU68495/00 A AU 68495/00A AU 6849500 A AU6849500 A AU 6849500A AU 6849500 A AU6849500 A AU 6849500A
- Authority
- AU
- Australia
- Prior art keywords
- negatively charged
- cationic lipid
- lipid compounds
- therapeutic interest
- charged substances
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
- C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9910141 | 1999-08-04 | ||
FR9910141A FR2797188A1 (en) | 1999-08-04 | 1999-08-04 | CATIONIC LIPID COMPOUNDS AND THEIR USE FOR THE TRANSFER OF NEGATIVELY CHARGED SUBSTANCES OF THERAPEUTIC INTEREST |
PCT/FR2000/002234 WO2001011068A2 (en) | 1999-08-04 | 2000-08-03 | Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interest |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6849500A true AU6849500A (en) | 2001-03-05 |
Family
ID=9548888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU68495/00A Abandoned AU6849500A (en) | 1999-08-04 | 2000-08-03 | Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interest |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1218033A2 (en) |
AU (1) | AU6849500A (en) |
CA (1) | CA2381224A1 (en) |
FR (1) | FR2797188A1 (en) |
WO (1) | WO2001011068A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4423107A1 (en) * | 2021-10-29 | 2024-09-04 | ModernaTX, Inc. | Lipid amines |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5283185A (en) * | 1991-08-28 | 1994-02-01 | University Of Tennessee Research Corporation | Method for delivering nucleic acids into cells |
FR2726764B1 (en) * | 1994-11-14 | 1997-01-31 | Pasteur Merieux Serums Vacc | ADJUVANT FOR VACCINE COMPOSITION |
AU2911197A (en) * | 1996-05-24 | 1998-01-05 | Imperial College Of Science, Technology And Medicine | Polycationic sterol derivatives as transfection agents |
EP0910343A1 (en) * | 1996-07-03 | 1999-04-28 | University Of Pittsburgh | Emulsion formulations for hydrophilic active agents |
DE19631189A1 (en) * | 1996-08-02 | 1998-02-05 | Max Delbrueck Centrum | Novel cationic amphiphiles for liposomal gene transfer |
-
1999
- 1999-08-04 FR FR9910141A patent/FR2797188A1/en active Pending
-
2000
- 2000-08-03 AU AU68495/00A patent/AU6849500A/en not_active Abandoned
- 2000-08-03 EP EP00956608A patent/EP1218033A2/en not_active Withdrawn
- 2000-08-03 CA CA002381224A patent/CA2381224A1/en not_active Abandoned
- 2000-08-03 WO PCT/FR2000/002234 patent/WO2001011068A2/en active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
EP1218033A2 (en) | 2002-07-03 |
WO2001011068A3 (en) | 2002-05-02 |
CA2381224A1 (en) | 2001-02-15 |
WO2001011068A2 (en) | 2001-02-15 |
FR2797188A1 (en) | 2001-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG24044A (en) | pharmaceutical formulation of omeprazole | |
AU2002323151A1 (en) | Application of lipid vehicles and use for drug delivery | |
AU5936400A (en) | Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same | |
AU6011496A (en) | Improved pharmaceutical compositions for gene therapy | |
HUP0202103A2 (en) | 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives, their use, pharmaceutical compositions containing them, process for the preparation of the compounds and intermediates | |
AU4300701A (en) | Methods and compositions for administration of therapeutic reagents | |
AUPP609198A0 (en) | Use of non-peptidyl compounds for the treatment of insulin related ailments | |
AU9224498A (en) | Matrix for controlled delivery of highly soluble drugs | |
AU1041599A (en) | Therapeutic uses of triazolo-pyridazine derivatives | |
AU1267400A (en) | Pharmaceutical moxifloxacin preparation | |
AUPO727097A0 (en) | Method of treatment of hepatoma and pharmaceutical compositions for use therein | |
AU4078997A (en) | Cholinesterase inhibitors for treatment of parkinson's disease | |
GB9812056D0 (en) | Pharmaceutical composition for treatment of ibd and rbd | |
AU2177001A (en) | Use of indirubine derivatives for making medicines | |
AU4213299A (en) | Controlled release of substances | |
AU2512501A (en) | Use of trimebutine for treating pain | |
AU8869398A (en) | Medical apparatus for relief of pain | |
HUP0201405A3 (en) | Pharmaceutical composition for therapeutic use of melatonin | |
AU2670600A (en) | Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence | |
AU4417000A (en) | Novel pharmaceutical composition suitable for gene therapy | |
AU6849500A (en) | Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interest | |
AU4053700A (en) | Enhanced tissue and subcellular delivery of vitamin e compounds | |
AU2566201A (en) | Compounds and methods for the treatment of pain | |
AU5483600A (en) | Pharmaceutical materials and methods for their preparation and use | |
AU9685298A (en) | Device for administration of viscoelastic substance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |